T2 Biosystems, Inc. stock is down -31.31% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30% of the previous 9 December’s closed higher than November.
T2 Biosystems, Inc. develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples.